Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Induction Nab-paclitaxel vs Paclitaxel for Nasopharyngeal Carcinoma
NCT04015661Phase 2Unknown
- Sponsor
- 900th Hospital of Joint Logistics Support Force of PLA
- Start
- Jul 2019
- Primary completion
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of paclitaxel in nasopharyngeal carcinoma (NPC), sponsored by 900th Hospital of Joint Logistics Support Force of PLA. Status: unknown.
02
Drugs
paclitaxel
03
Conditions
nasopharyngeal carcinoma (NPC)
Beyond the preview
Go deeper on NCT04015661.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04015661.